2026– date –
-
Amazon Bio Discovery Integrates UX-Driven AI Agents and Lab Connectivity within AWS AI Drug Discovery Platform to ‘Democratize’ Drug Discovery
IntuitionLabs USA Overview Amazon Bio Discovery, an AWS-powered AI drug discovery platform, integrates UX-driven AI agents, a curated library of biology-focused AI models, and built-in lab connectivity to 'democratize' the drug discovery... -
AI Drug Discovery Investment Surges to $10 Billion in 2026 with Eli Lilly Partnerships and Over 173 Clinical Programs, Highlighting Isomorphic Labs
MarketWise USA Overview Investment in AI drug discovery is booming in 2026, following Anthropic's CEO's prediction of a biotech renaissance, with AI and ML-related biopharma deals already nearing $10 billion. Key drivers include Eli Lill... -
2026 AI Chip Market Sees 44.6% Surge in Cloud Provider Custom ASIC Shipments, Challenging NVIDIA’s GPU Dominance
AIMultiple International Overview In the 2026 AI chip market, while NVIDIA's GPUs remain central, custom ASIC shipments from cloud providers are surging 44.6% year-over-year, reshaping the market structure. AIMultiple's analysis shows AS... -
Curtiss-Wright Details ‘Unspoken Challenges’ of Edge AI in Harsh Environments: Robust Systems Overcome Thermal, Power, and SWaP Constraints
Curtiss-Wright Defense Solutions USA Overview Curtiss-Wright Defense Solutions highlighted the 'hard problems no one talks about' in edge AI implementation, including thermal management, power consumption, bandwidth, ruggedization, lifec... -
World’s Largest Chemical Reactions Database Launched to Boost AI Drug Discovery, Revolutionizing New Drug Identification
New Scientist UK Overview The world's largest chemical reactions database has been launched to drive breakthroughs in AI drug discovery. This pioneering resource establishes a foundational base for AI-driven chemistry, promising to drama... -
EU AI Act Delays High-Risk AI System Obligations to December 2, 2027, Granting Industry More Time for Compliance Preparation
Morgan Lewis Europe Overview The European Parliament has approved amendments delaying the application of certain EU AI Act obligations, specifically for high-risk AI systems, to December 2, 2027 (originally August 2, 2026). This decision... -
Leading AI Drug Discovery Platforms Evolve from Candidate Generation to Protein Design in 2026, Driven by Eli Lilly-Insilico Medicine $2.75 Billion Partnership
The AI Journal USA Overview In 2026, AI drug discovery platforms, led by Converge Bio, Xaira Therapeutics, and Generate Biomedicines, have advanced beyond mere drug prediction to encompass candidate generation, antibody engineering, targ... -
Domo Unveils AI Agent Platform for Data-Driven Teams, Competing with Salesforce Agentforce and Google Vertex AI Agent Builder
Domo USA Overview Domo has launched an AI agent platform for data-driven teams, enabling the creation of autonomous programs capable of reasoning, acting, and completing tasks. This platform can execute API calls and database queries, ad... -
STMicroelectronics Advances Edge AI with STM32, Enabling Real-time Processing via ST Edge AI Suite for Model Optimization and C Code Compilation
STMicroelectronics Community Switzerland Overview STMicroelectronics is enabling Edge AI directly on STM32 microcontrollers and microprocessors, delivering superior power efficiency, ultra-low latency, real-time applications, and enhance... -
Crunchbase Data Reveals US AI Startup Funding to Dominate Globally with $319 Billion by 2026, Widening Gap with Non-US Counterparts
Crunchbase USA Overview According to the latest Crunchbase data, AI startup funding is overwhelmingly concentrated in the US, projected to reach $319 billion by 2026. This starkly contrasts with the $45 billion raised by non-US startups,...
